Herpetic whitlow - Revision history

Josgood: /* Clinical Features */

2022-05-19T23:20:37Z

Clinical Features

← Older revision		Revision as of 23:20, 19 May 2022
Line 9:		Line 9:
	[[File:PMC4236959 CRIOR2014-906487.003.png\|thumb\|Herpetic whitlow with erythema and vesicles.]]		[[File:PMC4236959 CRIOR2014-906487.003.png\|thumb\|Herpetic whitlow with erythema and vesicles.]]
	*Same burning, pruritic sensation as from other herpes infections		*Same burning, pruritic sensation as from other herpes infections
	*Vesicular ~~ullae~~		*Vesicular bullae
	*Finger may be indurated and tender (but should not be tense, as in a felon)		*Finger may be indurated and tender (but should not be tense, as in a felon)
	*Rash develops over 7-10 days, with possible ulceration and rupture		*Rash develops over 7-10 days, with possible ulceration and rupture

2020-01-28T21:47:55Z

Clinical Features

← Older revision		Revision as of 21:47, 28 January 2020
Line 7:		Line 7:
	==Clinical Features==		==Clinical Features==
	[[File:Herpetic whitlow in young child.jpg\|thumbnail\|Herpetic whitlow]]		[[File:Herpetic whitlow in young child.jpg\|thumbnail\|Herpetic whitlow]]
			[[File:PMC4236959 CRIOR2014-906487.003.png\|thumb\|Herpetic whitlow with erythema and vesicles.]]
	*Same burning, pruritic sensation as from other herpes infections		*Same burning, pruritic sensation as from other herpes infections
	*Vesicular ullae		*Vesicular ullae

2019-09-24T04:24:00Z

Management

← Older revision		Revision as of 04:24, 24 September 2019
Line 23:		Line 23:

	==Management==		==Management==
	*Immobilization, elevation, analgesia		*Immobilization, elevation, [[analgesia]]
	===~~Anitivirals~~===		===[[Antivirals]]===
	''~~Ativirals~~ such as [[Acyclovir]] or [[Valacyclovir]] may shorten duration of infection<ref name="treatment">Nikkels AF, Pierard GE. Treatment of mucocutaneous presentations of herpes simplex virus infections. Am J Clin Dermatol. 2002;3(7):475-87.</ref>''		''Antivirals such as [[Acyclovir]] or [[Valacyclovir]] may shorten duration of infection<ref name="treatment">Nikkels AF, Pierard GE. Treatment of mucocutaneous presentations of herpes simplex virus infections. Am J Clin Dermatol. 2002;3(7):475-87.</ref>''
	*Topical acyclovir 5% shortens duration and viral shedding in primary infection<ref name="treatment"></ref>		*Topical [[acyclovir]] 5% shortens duration and viral shedding in primary infection<ref name="treatment"></ref>
	*Oral [[acyclovir]] dosing - 800mg BID initiated during prodrome may prevent recurrence		*Oral [[acyclovir]] dosing - 800mg BID initiated during prodrome may prevent recurrence

2016-07-24T03:44:15Z

Text replacement - "==Diagnosis==" to "==Evaluation=="

2016-07-19T04:52:55Z

Text replacement - "0 mg" to "0mg"

← Older revision		Revision as of 04:52, 19 July 2016
Line 27:		Line 27:
	''Ativirals such as [[Acyclovir]] or [[Valacyclovir]] may shorten duration of infection<ref name="treatment">Nikkels AF, Pierard GE. Treatment of mucocutaneous presentations of herpes simplex virus infections. Am J Clin Dermatol. 2002;3(7):475-87.</ref>''		''Ativirals such as [[Acyclovir]] or [[Valacyclovir]] may shorten duration of infection<ref name="treatment">Nikkels AF, Pierard GE. Treatment of mucocutaneous presentations of herpes simplex virus infections. Am J Clin Dermatol. 2002;3(7):475-87.</ref>''
	*Topical acyclovir 5% shortens duration and viral shedding in primary infection<ref name="treatment"></ref>		*Topical acyclovir 5% shortens duration and viral shedding in primary infection<ref name="treatment"></ref>
	*Oral [[acyclovir]] dosing - ~~800 mg~~ BID initiated during prodrome may prevent recurrence		*Oral [[acyclovir]] dosing - 800mg BID initiated during prodrome may prevent recurrence

	===Secondary Prevention===		===Secondary Prevention===

2016-07-13T10:13:53Z

Text replacement - " w/ " to " with "

← Older revision		Revision as of 10:13, 13 July 2016
Line 1:		Line 1:
	==Background==		==Background==
	*[[HSV]] infection of distal finger<ref>Wu IB, Schwartz RA. Herpetic whitlow. Cutis. Mar 2007;79(3):193-6</ref>		*[[HSV]] infection of distal finger<ref>Wu IB, Schwartz RA. Herpetic whitlow. Cutis. Mar 2007;79(3):193-6</ref>
	**Usually occurs from contact w/ oral herpes, or autoinoculation from genital herpes		**Usually occurs from contact with oral herpes, or autoinoculation from genital herpes
	**Incubation period of 2-20 days, with possible prodrome of fever or malaise		**Incubation period of 2-20 days, with possible prodrome of fever or malaise
	**60% due to HSV-1, 40% due to HSV-2		**60% due to HSV-1, 40% due to HSV-2

2016-07-08T20:30:04Z

Text replacement - "==Treatment==" to "==Management=="

← Older revision		Revision as of 20:30, 8 July 2016
Line 22:		Line 22:
	{{HSV-1 standard diagnosis}}		{{HSV-1 standard diagnosis}}

	==~~Treatment~~==		==Management==
	*Immobilization, elevation, analgesia		*Immobilization, elevation, analgesia
	===Anitivirals===		===Anitivirals===

2016-04-25T21:33:39Z

Diagnosis

← Older revision		Revision as of 21:33, 25 April 2016
Line 20:		Line 20:

	==Diagnosis==		==Diagnosis==
	*If unsure of diagnosis ~~can unroof a vesicle and send fluid for a Tzanck smear~~		{{HSV-1 standard diagnosis}}

	==Treatment==		==Treatment==

2016-04-25T21:25:04Z

Treatment

← Older revision		Revision as of 21:25, 25 April 2016
Line 30:		Line 30:

	===Secondary Prevention===		===Secondary Prevention===
	*Application of clean dressings to involved digits is important to prevent autoinoculation or spread to other individuals		*Application of clean dressings to involved digits is important to prevent autoinoculation or spread to other individuals

			==Disposition==
			*Outpatient managment

	==See Also==		==See Also==

2016-03-22T15:47:54Z

Text replacement - "Category:Ortho" to "Category:Orthopedics"